Literature DB >> 1443549

Detection of receptor-ligand interactions using surface plasmon resonance: model studies employing the HIV-1 gp120/CD4 interaction.

M Brigham-Burke1, J R Edwards, D J O'Shannessy.   

Abstract

Surface plasmon resonance (SPR), a label-free, real time optical detection principle, has been investigated for its potential to detect and quantitate macromolecular ligand-ligate interactions. As model systems, the interactions of the HIV-1 envelope glycoprotein, gp120, and the monoclonal antibody L-71, with a soluble form of the T-cell receptor CD4 (sCD4), were investigated. In an effort to demonstrate potential analytical applications of this technology, operational characteristics of the SPR instrumentation (BIAcore, Pharmacia) including stability of the sensing surface and reproducibility in the measurement of such macromolecular interactions were investigated. In addition, the ability to detect and quantitate sCD4 directly from unfractionated cell culture supernatants, such as Streptomyces lividans, was investigated. The results demonstrate that SPR has potential in quantitating macromolecular interactions in both purified and crude samples and that the reproducibility in, and sensitivity of, such determinations is comparable to other techniques.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1443549     DOI: 10.1016/0003-2697(92)90588-x

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  13 in total

1.  Enzyme mimicry by the antiidiotypic antibody approach.

Authors:  A V Kolesnikov; A V Kozyr; E S Alexandrova; F Koralewski; A V Demin; M I Titov; B Avalle; A Tramontano; S Paul; D Thomas; A G Gabibov; A Friboulet
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

Review 2.  Evanescent wave biosensors. Real-time analysis of biomolecular interactions.

Authors:  A M Hutchinson
Journal:  Mol Biotechnol       Date:  1995-02       Impact factor: 2.695

3.  Biointeraction analysis of immobilized antibodies and related agents by high-performance immunoaffinity chromatography.

Authors:  Erika Pfaunmiller; Annette C Moser; David S Hage
Journal:  Methods       Date:  2011-09-01       Impact factor: 3.608

4.  Interaction with CD4 and antibodies to CD4-induced epitopes of the envelope gp120 from a microglial cell-adapted human immunodeficiency virus type 1 isolate.

Authors:  Julio Martín-García; Simon Cocklin; Irwin M Chaiken; Francisco González-Scarano
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

5.  The alpha-glucosidase inhibitor N-butyldeoxynojirimycin inhibits human immunodeficiency virus entry at the level of post-CD4 binding.

Authors:  P B Fischer; M Collin; G B Karlsson; W James; T D Butters; S J Davis; S Gordon; R A Dwek; F M Platt
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

6.  Biointeraction analysis by high-performance affinity chromatography: Kinetic studies of immobilized antibodies.

Authors:  Mary Anne Nelson; Annette Moser; David S Hage
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2009-04-08       Impact factor: 3.205

7.  Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro.

Authors:  T B McNeely; M Dealy; D J Dripps; J M Orenstein; S P Eisenberg; S M Wahl
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

8.  Detection of platelet-derived growth factor (PDGF)-AA in actively healing human wounds treated with recombinant PDGF-BB and absence of PDGF in chronic nonhealing wounds.

Authors:  G F Pierce; J E Tarpley; J Tseng; J Bready; D Chang; W C Kenney; R Rudolph; M C Robson; J Vande Berg; P Reid
Journal:  J Clin Invest       Date:  1995-09       Impact factor: 14.808

9.  N-butyldeoxynojirimycin-mediated inhibition of human immunodeficiency virus entry correlates with changes in antibody recognition of the V1/V2 region of gp120.

Authors:  P B Fischer; G B Karlsson; T D Butters; R A Dwek; F M Platt
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

10.  Neu differentiation factor upregulates epidermal migration and integrin expression in excisional wounds.

Authors:  D M Danilenko; B D Ring; J Z Lu; J E Tarpley; D Chang; N Liu; D Wen; G F Pierce
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.